These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38957334)

  • 21. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.
    Cheng MP; Cau A; Lee TC; Brodie D; Slutsky A; Marshall J; Murthy S; Lee T; Singer J; Demir KK; Boyd J; Ohm H; Maslove D; Goffi A; Bogoch II; Sweet DD; Walley KR; Russell JA;
    Crit Care Med; 2021 Sep; 49(9):1558-1566. PubMed ID: 33870918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
    Beyerstedt S; Casaro EB; Rangel ÉB
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
    Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
    Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
    Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
    Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.
    Amirfakhryan H; Safari F
    Hellenic J Cardiol; 2021; 62(1):13-23. PubMed ID: 32522617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored.
    Wang Y; Roever L; Tse G; Liu T
    Curr Atheroscler Rep; 2020 May; 22(3):14. PubMed ID: 32415481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
    Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
    Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
    Rochette L; Ghibu S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline.
    Pyne JD; Brickman AM
    Neurodegener Dis; 2021; 21(1-2):1-23. PubMed ID: 34348321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
    Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
    Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
    Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
    Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.